Cantitate/Preț
Produs

Nonlinear Models for Medical Statistics: Oxford Statistical Science Series, cartea 26

Autor J. K. Lindsey
en Limba Engleză Hardback – 18 iul 2001
This text provides an introduction to the use of nonlinear models in medical statistics, It is a practical text rather than a theoretical one and assumes a basic knowledge in statistical modelling and of generalized linear models. The book first provides a general introduction to nonlinear models, comparing them to generalized linear models. It describes data handling and formula definition and summarises the principal types of nonlinear regression formulae. there is an emphasis on techniques for non-normal data.Following chapters provide detailed examples of applications in various areas of medicine, epidemiology, clinical trials, quality of life, pharmokinetics, pharmacodynamics, assays and formulations, and molecular genetics.The book concludes with appendicies describing data handling and model formulae in more detail, and given ways of modelling dependencies in repeated measurements, and data for the exercises.
Citește tot Restrânge

Din seria Oxford Statistical Science Series

Preț: 95608 lei

Preț vechi: 124166 lei
-23% Nou

Puncte Express: 1434

Preț estimativ în valută:
18297 19006$ 15199£

Carte tipărită la comandă

Livrare economică 01-15 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780198508120
ISBN-10: 0198508123
Pagini: 292
Ilustrații: numerous tables and figures
Dimensiuni: 161 x 242 x 21 mm
Greutate: 0.56 kg
Editura: OUP OXFORD
Colecția OUP Oxford
Seria Oxford Statistical Science Series

Locul publicării:Oxford, United Kingdom

Recenzii

This book is a great introduction to the topic of nonlinear models and is probably the only book that deals with some of the concepts. Lindsey's writing style makes easy reading and very useful reference ... this book is a must for those working in early phase clinical trials, particularly in the discipline of pharmacokinetics and pharmacodynamics.
The book would benefit primarily those statisticians working in exploratory fields, particularly early drug development. It would also benefit those working in pharmacokinetics and pharmacodynamics.